· 2022–2024 · DOL EFAST2
Search
Browse
Resources
Pricing
TAVANTA THERAPEUTICS, INC. — TAVANTA THERAPEUTICS, INC. 401(K) PROFIT SHARING PLAN & TRUST, Form 5500 (2023) | Form 5500 Search
Back to filter
Original filing (PDF)
20251024125010NAL0002737219001
TAVANTA THERAPEUTICS, INC.
Form 5500-SF
FILING_RECEIVED
TAVANTA THERAPEUTICS, INC. 401(K) PROFIT SHARING PLAN & TRUST
401(k) retirement plan
Signals · 1
Late filing · 14.0 mo
Active participants
0
Accounts w/ balance
0
Plan assets (EOY)
$0
Net assets (EOY)
$0
Plan health score (directional)
81
/ 100
Grade B
Above-average plan
Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.
Compliance & disclosures
75
Concentration risk
75
Total plan cost
75
Vendor stack
100
Participation health
Decision-maker contacts
CFO / Head of HR / Benefits Manager — verified email + LinkedIn for
TAVANTA THERAPEUTICS, INC.
.
Find decision makers
Plan sponsor
Name
TAVANTA THERAPEUTICS, INC.
EIN
85-1292307
Address
1000 FIRST AVENUE · SUITE 405 · KING OF PRUSSIA, PA · 19406
Phone
(908) 240-9523
Industry
Manufacturing
see all
Plan administrator
Same as plan sponsor.
Plan characteristics
Plan number
001
Plan year
2023
Plan year begin
2023-01-01
Tax period
2023-10-09
Filed
2025-10-24
Pension benefit codes
2E · Profit-sharing
2F · ERISA section 404(c)
2G · Total participant-directed accounts
2J · 401(k) feature
2K · 401(m) arrangement
2T · Default investment account (QDIA)
3D · Pre-approved plan (master / prototype / VS)
Audit & trust (Schedule H)
Service providers (Schedule C)
Small plans don't disclose service providers
Related plans
Similar-size Manufacturing plans
HOFFMANN-LA ROCHE INC.
ROCHE U.S. RETIREMENT PLAN
$0
ANALGESIC SERVICES, INC. AZ
ANALGESIC SERVICES INC. AZ 401(K) PLAN
$0
LONGBOARD PHARMACEUTICALS, INC.
LONGBOARD PHARMACEUTICALS 401(K) PLAN
$0
NEW VISION PHARMACEUTICALS, LLC
NEW VISION PHARMACEUTICALS, LLC 401(K) PLAN
$0
VIRAQUEST, INC.
VIRAQUEST, INC. 401(K) RETIREMENT PLAN
$0
100
Knocking points off
Filed 14.0 months past the 10.5-month grace window.
Helping the score
Concentration not scored — Schedule of Assets PDF not yet parsed for this plan.
No Schedule C compensation disclosed — likely a small plan or unbundled.
Auditor
—
Trustee / custodian
—
Trustee phone
—
Small plan (5500-SF) — Schedule H data not available.
ONCTERNAL THERAPEUTICS INC.
ONCTERNAL THERAPEUTICS INC. 401(K) PLAN
$0
Large plans in Pennsylvania
VANGUARD FIDUCIARY TRUST COMPANY
VANGUARD FIDUCIARY TRUST COMPANY INSTITUTIONAL TOTAL INTERNATIONAL STOCK MARKET INDEX TRUST II
$223.1B
VANGUARD FIDUCIARY TRUST COMPANY
VFTC INSTITUTIONAL 500 INDEX TRUST
$183.5B
VANGUARD FIDUCIARY TRUST COMPANY
VANGUARD FIDUCIARY TRUST COMPANY TARGET RETIREMENT 2035 MASTER TRUST
$116.3B
VANGUARD FIDUCIARY TRUST COMPANY
VANGUARD FIDUCIARY TRUST COMPANY TARGET RETIREMENT 2045 MASTER TRUST
$109.4B
VANGUARD FIDUCIARY TRUST COMPANY
VANGUARD FIDUCIARY TRUST COMPANY TARGET RETIREMENT 2040 MASTER TRUST
$108.2B
VANGUARD FIDUCIARY TRUST COMPANY
VANGUARD FIDUCIARY TRUST COMPANY TARGET RETIREMENT 2030 MASTER TRUST
$106.2B